Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
AI Lab for Defence and National Security
SenseOn provides accurate and context-rich alerts.
PhoreMost is a new-model drug discovery company based in Cambridge, UK.
Unlikely AI is a talented group that is approaching artificial intelligence from a daring, fresh angle.
Respiro Diagnostics develops non-invasive breath-based diagnostic tests for early detection of lung cancer and other respiratory diseases.
Sensity AI detects deepfakes and manipulated media using AI for security and verification purposes.
Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
Pressure Sensitive Multi-Touch for Next-Generation Smart Devices including Smartphones, Tablets, Automotive and Industrial
Slamcore creates embedded software that uses vision to help products intelligently understand and navigate the worlds around them.
At Constructive Bio we rewrite genomes to build the biomolecules of the future.
Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.
Software for mobile robots
At Atto, we provide instant insights into the financial behaviours of borrowers through real-time transaction data.
iPronics has pioneered the field of software-defined photonics and introduces the world's first optical circuit switch.
Sitehop develops cutting-edge networking and cyber-security solutions.
Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.
Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.
Pimloc's deep learning SaaS platform, Secure Redact, enables public and private organisations to protect personal data in video at scale.
OrganOx is a medical technology company.
Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
fileAI is a horizontal file processing and AI-driven workflow automation platform that streamlines unstructured data processing at scale.
Refute identifies and addresses misinformation on behalf of there businesses.
Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.
Riverlane develops software solutions to harness the power of quantum computers for practical applications.
Amadeus Capital Partners has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Amadeus Capital Partners's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Machine Learning, Health Care. The firm invests across 45 different industry categories.
Among tracked funding rounds, OrganOx received $160.0M in a Venture - Series Unknown round. Amadeus Capital Partners's total known invested capital is $1.8B.
Amadeus Capital Partners's average investment size is $26.9M across its portfolio of 79 companies.
Recent Amadeus Capital Partners portfolio additions include Offset Labs, SenseOn, PhoreMost, Unlikely AI, Respiro Diagnostics. These companies were founded in 2020 or later.